iopamidol has been researched along with Dyslipidemia in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Inoue, K; Kimura, F; Kozawa, E; Matsuo, Y; Mizukoshi, W; Nakajima, T; Sakai, F | 1 |
Aihara, H; Aonuma, K; Endo, M; Kawano, S; Maruyama, H; Saito, T; Sakai, S; Sato, A; Shimojo, N; Tajiri, K; Watanabe, S | 1 |
2 other study(ies) available for iopamidol and Dyslipidemia
Article | Year |
---|---|
CT features of myocardial fat and correlation with clinical background in patients without cardiac disease.
Topics: Adipose Tissue; Adolescent; Adult; Aged; Aged, 80 and over; Body Mass Index; Cardiac-Gated Imaging Techniques; Contrast Media; Diabetes Complications; Dyslipidemias; Female; Humans; Hypertension; Iohexol; Iopamidol; Male; Middle Aged; Myocardium; Tomography, X-Ray Computed | 2013 |
Prediction of chronic renal insufficiency after coronary angiography by an early increase in oxidative stress and decrease in glomerular filtration rate.
Topics: Acetylglucosaminidase; Acute Kidney Injury; Aged; Biomarkers; Contrast Media; Coronary Angiography; Creatinine; Diabetes Mellitus; Dyslipidemias; F2-Isoprostanes; Female; Glomerular Filtration Rate; Humans; Hypertension; Iopamidol; Kidney Failure, Chronic; Kidney Function Tests; Male; Middle Aged; Oxidative Stress; Prospective Studies; Risk Factors | 2011 |